Archives
Pasadena, CA, April 7, 2025 – FlemingMartin is pleased to announce that Xencor, a clinical-stage biopharmaceutical company focusing on the treatment of patients with cancer and autoimmune diseases, has hired Raul Acosta as their Senior…
Tempe, AZ, March 24, 2025 – FlemingMartin is pleased to announce that Amkor Technology, the world’s largest U.S. headquartered OSAT (outsourced semiconductor assembly and test) service provider, has hired Donna Fagan as their Head of…
In March 2025, FlemingMartin convened roundtable discussions with more than 100 Chief People Officers (CPOs) from leading Technology and Life Science companies across the United States. These conversations provided valuable insights into the priorities and…
Redwood City, CA, February 24, 2025 – FlemingMartin is pleased to announce that Revolution Medicines (Nasdaq: RVMD), a late clinical stage oncology company developing novel targeted therapies for RAS-addicted cancers, has hired Brad Turcott as…
San Francisco, CA, February 21, 2025 – FlemingMartin is pleased to announce that Iterable, an AI-powered customer communication platform, has hired Jim Bartolomea as their Chief People Officer. Jim Bartolomea is a seasoned People leader…
Westlake Village, CA January 30, 2025 – FlemingMartin is pleased to announce that Genelux (NASDAQ: GNLX), a leading innovator in the field of cancer immunotherapy, has hired Matt Pulisic as their Chief Financial Officer. Most…
In the first week of December 2024, FlemingMartin hosted roundtable discussions with almost 100 Chief People Officers (CPOs) from leading Technology and Life Science companies throughout the United States. Topics included: Below are the key…
South San Francisco, CA, November 18, 2024 – FlemingMartin is pleased to announce that Cytokinetics (NASDAQ: CYTK), a late clinical stage biopharmaceutical company dedicated to discovering, developing, and commercializing first-in-class muscle activators and next-in-class muscle…
South San Francisco, CA, November 6, 2024 – FlemingMartin is pleased to announce that Alumis, a clinical-stage biopharmaceutical company developing novel oral therapies to treat immune-mediated diseases, has hired Dr. Rajesh “Raj” Punwaney as Vice…
South San Francisco, CA, October 28, 2024 – FlemingMartin is pleased to announce that Alumis, a clinical-stage biopharmaceutical company developing novel oral therapies to treat immune-mediated diseases, has hired Dr. Elisa Muscianisi as Vice President…
In September 2024, FlemingMartin organized roundtable discussions with more than 100 Chief People Officers (CPOs) from leading Technology and Life Science companies. Topics included: We have summarized key themes from these discussions below and provided…
Arlington, VA, September 16, 2024 – FlemingMartin is pleased to announce that AeroVironment, a leading, tech-enabled American company that designs and manufactures unmanned aerial and ground vehicles, has hired Archana Nirwan as its new Chief…
South San Francisco, CA, September 16, 2024 – FlemingMartin is pleased to announce that Circle Pharma, a clinical-stage biopharmaceutical company dedicated to discovering and developing cell-permeable macrocycle therapies, has hired Clovis Célestin as Executive Director…
New York City, NY, September 3, 2024 – FlemingMartin is pleased to announce the appointment of Paul McConville to the Brainfuse Board of Directors. Paul is currently the CEO of Thesis where he is responsible…
Los Altos, CA, August 19, 2024 – FlemingMartin is pleased to announce that Afero, a market leader in the Internet of Things (IoT) space, has hired Dilip Kenchammana as their Chief Product and Partnerships Officer.…